1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMedical Devices (MD) is sponsored by National Science Foundation (NSF) SBIR/STTR. This NSF SBIR/STTR topic supports the development of novel medical device platforms, innovative medical technologies, or the translation of emerging scientific principles into health practice.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Medical Devices Grant – Apply Today | NSF SBIR For proposal preparation and submission instructions, click here . The SBIR/STTR program looks forward to receiving the submission of new Project Pitches in response to the new solicitations beginning on Tuesday, June 2, 2026. Please direct any questions to sbir@nsf.
gov . The Neural Analytics Lucid™ M1 transcranial Doppler Ultrasound System is indicated as an adjunct to the standard clinical practices for measuring and displaying cerebral blood flow velocity within the major conducting arteries and veins of the head and neck. Additionally, the Lucid™ M1 System measures the occurrence of transient emboli signals within the blood stream.
The Medical Devices topic aims to develop novel medical device platforms, introduce innovative medical technologies or translate emerging scientific principles into health practice. Proposals should be considered leading edge innovations, typically based on a discovery, new approach or new scientific principle to medical devices or technologies.
Limited human subject clinical studies may be acceptable if they are performed in support of feasibility or proof-of-concept objectives. The program does not support proposals to conduct clinical trials for sample size calculations, statistically demonstrate safety or efficacy or the development of pre-clinical or clinical-stage drug candidates.
Clinical work performed primarily for regulatory purposes or post market surveillance are also not allowed. Proposals requesting support for clinical trials are noncompliant with the SBIR/STTR solicitation and returned without review . MD1.
Diagnostic Imaging or Monitoring MD2. General Medical Devices MD4. Manufacturing Processes or Prototyping Methods MD5.
Materials (non biological) MD6. Procedural Technologies or Visualization Application process for Medical Devices (MD) funding Eligibility for Medical Devices (MD) funding + Your company must be a small business (fewer than 500 employees) located in the United States. At least 50% of your company’s equity must be owned by U.S. citizens or permanent residents.
NSF does not fund companies that are majority-owned by multiple venture capital firms, private equity firms, or hedge funds, to participate in SBIR and STTR. All funded work, including work done by consultants and contractors, needs to take place in the United States. The project’s principal investigator (tech lead) must be legally employed at least 20 hours a week by the company seeking funding.
The principal investigator doesn’t need any advanced degrees. The principal investigator needs to commit to at least one month (173 hours) of work on a funded project per six months of project duration. Evaluation Criteria: What We Look for When Evaluating Medical Devices (MD) proposals + Take our project assessment to see if your work might be a good fit for NSF funding.
Device to treat stress urinary incontinence in women Elidah created a medical device to help women with stress urinary incontinence - the inability to control the urge to urinate - a condition which impacts about one in three women. To learn more visit: https://www. elidah.
com/ We invest up to $2 million in seed funding and take zero equity. We’re looking for companies that are transformative, high-risk, have a market pull, and are scaleable.
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: U. S. -based small businesses (fewer than 500 employees) with at least 50% U. S. ownership. The program does not support clinical trials for statistically demonstrating safety or efficacy or for regulatory purposes. Confirm the full requirements in the official notice before applying.
The current listing shows varies (Phase I: up to $305,000; Phase II: up to $1,250,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Medical Devices (MD) is funded by National Science Foundation (NSF) SBIR/STTR. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
NSF's restarted SBIR/STTR program carries two transition rules almost nobody has calendared. Project Pitch invitations issued on or after July 3, 2025 must be converted to a full proposal by November 4, 2026. Phase I awardees whose awards started on or after November 6, 2023 must submit Phase II by the same date. Both cohorts were created by the program lapse, and both cliffs are hard.
Read articleNSF's rebuilt SBIR/STTR program (NSF 26-510) pairs a $305,000 Phase I with a brand-new Strategic Breakthrough award worth up to $30 million for the strongest Phase II companies. The next Project Pitch deadline is July 27, 2026. Here is how the non-dilutive funding ladder now works, why the Project Pitch gate decides everything, and how a founder should sequence the next twelve months.
Read articleAfter a disruptive pause, NSF has reopened its SBIR/STTR programs with $250 million for deep-tech startups — including a $40M scientific-instrumentation pilot and a new Strategic Breakthrough track that can reach $30 million. The first Project Pitch deadline is July 27, 2026. Here is how the reopened pipeline works, why the Project Pitch is the real gate, and how founders should sequence a submission before the window narrows.
Read article